Free Trial

Bridges Investment Management Inc. Trims Position in Chemed Co. (NYSE:CHE)

Chemed logo with Medical background
Remove Ads

Bridges Investment Management Inc. trimmed its holdings in shares of Chemed Co. (NYSE:CHE - Free Report) by 6.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 67,473 shares of the company's stock after selling 4,756 shares during the quarter. Bridges Investment Management Inc. owned about 0.45% of Chemed worth $35,747,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in CHE. FMR LLC grew its stake in Chemed by 23.8% in the 3rd quarter. FMR LLC now owns 238,616 shares of the company's stock worth $143,401,000 after buying an additional 45,917 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in shares of Chemed by 114.1% during the 4th quarter. Principal Financial Group Inc. now owns 74,658 shares of the company's stock worth $39,554,000 after acquiring an additional 39,791 shares during the last quarter. Thrivent Financial for Lutherans grew its position in Chemed by 25.3% in the third quarter. Thrivent Financial for Lutherans now owns 146,017 shares of the company's stock worth $87,752,000 after acquiring an additional 29,445 shares in the last quarter. Aureus Asset Management LLC increased its stake in Chemed by 3,147.2% in the third quarter. Aureus Asset Management LLC now owns 29,939 shares of the company's stock valued at $17,993,000 after acquiring an additional 29,017 shares during the last quarter. Finally, Boston Trust Walden Corp increased its stake in Chemed by 10.0% in the fourth quarter. Boston Trust Walden Corp now owns 242,172 shares of the company's stock valued at $128,303,000 after acquiring an additional 22,105 shares during the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Chemed Stock Up 1.3 %

Shares of Chemed stock traded up $7.42 during trading on Wednesday, reaching $595.07. The company's stock had a trading volume of 106,099 shares, compared to its average volume of 98,536. The company has a market cap of $8.96 billion, a price-to-earnings ratio of 30.07, a PEG ratio of 2.15 and a beta of 0.48. The firm's 50-day moving average is $549.47 and its two-hundred day moving average is $563.54. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $654.62.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, February 24th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.34%. Chemed's dividend payout ratio (DPR) is currently 10.05%.

Insider Transactions at Chemed

In related news, VP Brian C. Judkins purchased 145 shares of Chemed stock in a transaction that occurred on Monday, December 30th. The shares were acquired at an average cost of $519.50 per share, for a total transaction of $75,327.50. Following the transaction, the vice president now directly owns 1,678 shares in the company, valued at $871,721. The trade was a 9.46 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 3.32% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the company. Royal Bank of Canada cut their price objective on Chemed from $697.00 to $633.00 and set an "outperform" rating for the company in a report on Tuesday, November 5th. StockNews.com downgraded Chemed from a "buy" rating to a "hold" rating in a research report on Thursday, February 27th.

View Our Latest Stock Report on CHE

Chemed Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

See Also

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Archer Aviation: Sinking Now, Soaring Soon?

Archer Aviation: Sinking Now, Soaring Soon?

MarketBeat analyst Gabriel Osario-Mazilli breaks down what’s next for Archer and how investors should play this move.

Recent Videos

AMD at Rock Bottom? Analysts Predict a MAJOR Rebound!
Massive Buybacks: 3 Stocks Insiders Are Buying Up
Tesla Sinks on Musk Drama—Bounce or Bigger Crash?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads